VOLUME: 19 ISSUE: 2

Ö Aydemir, A Üçok, AE Danacı, T Canpolat, G Karadayı, B Emiroğlu, F Sarıöz
The validation of Turkish version of personal and social performance scale (PSP)
Klinik Psikofarmakoloji Bulteni – Bulletin of Clinical Psychopharmacology 2009;19(2):93-100

 
 
B Sönmez, E Vardar, GD Altun, E Abay, D Bedel
Ziprasidone versus risperidone: Comparison of clinical efficacy and cardiac, extrapyramidal, and metabolic side effects in patients with acute exacerbation of schizophrenia and schizoaffective disorders
Klinik Psikofarmakoloji Bulteni – Bulletin of Clinical Psychopharmacology 2009;19(2):101-112

 
 
Ö Geçici, A Ayçiçek, Ö Özbulut, K Duman, F Kenar, S Dereköy
Effects of selective serotonin reuptake inhibitors on auditory brainstem responses in patients with depressive disorder
Klinik Psikofarmakoloji Bulteni – Bulletin of Clinical Psychopharmacology 2009;19(2):113-118

 
 
O Virit, A Altindag, F Bulbul, HA Savas, A Dalkilic
Long-acting typical and atypical antipsychotics in treatment of schizophrenia: A retrospective comparison
Klinik Psikofarmakoloji Bulteni – Bulletin of Clinical Psychopharmacology 2009;19(2):119-127

 
 
C Başoğlu, MA Ateş, A Algül, OM İpçioğlu, Ö Geçici, O Yılmaz, ÜB Semiz, S Ebrinç, M Gülsün, Ö Özcan, S Kılıç, M Çetin
Adjuvant folate with escitalopram treatment and homocystein, folate, vitamin B-12 levels in patients with major depressive disorder
Klinik Psikofarmakoloji Bulteni – Bulletin of Clinical Psychopharmacology 2009;19(2):135-142

 
 
D Tuncel, FÖ Orhan, MF Karaaslan
The levels of depression and somatization in restless legs syndrome
Klinik Psikofarmakoloji Bulteni – Bulletin of Clinical Psychopharmacology 2009;19(2):143-147

 
 
S Özsoy, HB İzgi, E Eşel, T Turan, M Baştürk, S Sofuoğlu
The effects of pharmachotherapy on serum folic acid and vitamin B12 levels in patients with schizophrenia, bipolar disorder and major depressive disorder
Klinik Psikofarmakoloji Bulteni – Bulletin of Clinical Psychopharmacology 2009;19(2):128-134

 
 
C Evren, HT Karatepe, A Aydın, E Dalbudak, D Cakmak
The effect of quetiapine on alcohol/drug dependents and its abuse: A case series and literature review
Klinik Psikofarmakoloji Bulteni – Bulletin of Clinical Psychopharmacology 2009;19(2):148-154

 
 
M Coskun, S Zoroglu
Clozapine induced obsessions treated with sertraline in an adolescent with schizophrenia
Klinik Psikofarmakoloji Bulteni – Bulletin of Clinical Psychopharmacology 2009;19(2):155-158

 
 
ABO Girayalp
Galactorrhea due to şuoxetine in a patient with depression and a pituitary adenoma: A case report
Klinik Psikofarmakoloji Bulteni – Bulletin of Clinical Psychopharmacology 2009;19(2):159-163

 
 
C Açıkel
Meta-analysis and its place in evidence based medicine.
Klinik Psikofarmakoloji Bulteni – Bulletin of Clinical Psychopharmacology 2009;19(2):164-172

 
 
A Korkmaz, MA Ateş, A Algül, C Başoğlu
Physiological approach to neuropsychiatric diseases; role of autonomic nervous system and melatonin
Klinik Psikofarmakoloji Bulteni – Bulletin of Clinical Psychopharmacology 2009;19(2):173-182

 
 
C Göker, A Yılmaz, H Kumbasar
Is placebo efficacious? Ethical?
Klinik Psikofarmakoloji Bulteni – Bulletin of Clinical Psychopharmacology 2009;19(2):183-192

 
 
E Eşel
Probable cognitive and neurobiological mechanisms of religious and mystic experiences
Klinik Psikofarmakoloji Bulteni – Bulletin of Clinical Psychopharmacology 2009;19(2):193-205

 
 
N Havle, MC İlnem, F Yener, C Dayan
Patients with Very High Serum Lithium Levels May Not Have a Poor Clinical Outcome
Klinik Psikofarmakoloji Bulteni – Bulletin of Clinical Psychopharmacology 2009;19(2):206-207

 
 
AE Tufan
Proposal for A Preliminary Guideline to Predict The Treatment Cost of Attention Deficit- Hyperactivity Disorder (ADHD)
Klinik Psikofarmakoloji Bulteni – Bulletin of Clinical Psychopharmacology 2009;19(2):208-210

 
 
M Çetin, C Açıkel
In perspective of meta-analyses: Are all of the antidepressants similar?
Klinik Psikofarmakoloji Bulteni – Bulletin of Clinical Psychopharmacology 2009;19(2):87-92